ASRM

Boston IVF Showcases Pioneering Fertility Research at the 2023 ASRM Scientific Congress & Expo

Retrieved on: 
Thursday, October 19, 2023

BOSTON, Oct. 19, 2023 /PRNewswire-PRWeb/ -- Boston IVF, a renowned leader in fertility research and patient care since its establishment in 1986, is proud to announce its substantial participation in the 2023 American Society for Reproductive Medicine (ASRM) Scientific Congress and Expo. This prestigious annual event, in New Orleans, Louisiana, from October 14-18, brought together global experts to share groundbreaking advancements in technology, treatments, and patient care in reproductive medicine.

Key Points: 
  • Charting a Path to Tomorrow, Boston IVF's Groundbreaking Research in 2023 Continues to Shape the Future of Fertility Care
    BOSTON, Oct. 19, 2023 /PRNewswire-PRWeb/ -- Boston IVF , a renowned leader in fertility research and patient care since its establishment in 1986, is proud to announce its substantial participation in the 2023 American Society for Reproductive Medicine (ASRM) Scientific Congress and Expo .
  • – David Stern, CEO of Boston IVF
    Boston IVF's team of reproductive endocrinologists, scientists, clinicians, and researchers presented over 20 pioneering research studies, along with education symposia and roundtables.
  • This year, four distinguished individuals from Boston IVF were recognized nationally by the ASRM for their exceptional contributions:
    Yuval Fouks, MD, PhD, MPH a dedicated Research Fellow at Boston IVF, was honored with the ASRM 2023 IN TRAINING AWARD FOR RESEARCH for his noteworthy publication in Fertility and Sterility.
  • (Source: Fertility & Sterility)
    Quetrell Heyward, MD, MBA, a Reproductive Endocrinology and Infertility Fellow at Boston IVF & Beth Israel Deaconess Medical Center, received the prestigious ASRM 2023 INVESTIGATOR ACHIEVEMENT AWARD.

Chief Research Officer at US Fertility, Kate Devine, M.D., receives prestigious award from ASRM

Retrieved on: 
Wednesday, October 18, 2023

LOS ANGELES, Oct. 18, 2023 /PRNewswire-PRWeb/ -- US Fertility celebrates, Kate Devine, M.D., Medical Director and Chief Research Officer, who received the Ira and Ester Rosenwaks New Investigator Award of the American Society for Reproductive Medicine for 2023.

Key Points: 
  • , Medical Director and Chief Research Officer, who received the Ira and Ester Rosenwaks New Investigator Award of the American Society for Reproductive Medicine for 2023.
  • "I am incredibly humbled to receive such an honor and send gratitude to ASRM and my physician peers who have supported me," shares Dr. Devine.
  • The award was announced during ASRM's Opening Ceremony on Monday, October 16, 2023 and presented during the ASRM Research Symposium on Wednesday, October 18, 2023.
  • Learn more about US Fertility's Research Division , which conducts and publishes high-quality research studies to advance the field of reproductive medicine to provide better, more effective care to infertility patients.

IVIRMA Research Presented at ASRM 2023 Shapes the Future of Reproductive Medicine

Retrieved on: 
Wednesday, October 18, 2023

BASKING RIDGE, N.J., Oct. 18, 2023 /PRNewswire/ -- IVIRMA Global, the largest reproductive medicine group in the world, has a long history of pioneering research in the field of assisted reproductive technologies that has led to major advances in assisted reproduction. Many of today's standard practices, including elective single embryo transfer and preimplantation genetic testing for aneuploidy, have been shaped by the fertility group's innovative research efforts. 

Key Points: 
  • Many of today's standard practices, including elective single embryo transfer and preimplantation genetic testing for aneuploidy, have been shaped by the fertility group's innovative research efforts.
  • At the recently concluded American Society of Reproductive Medicine (ASRM) 2023 conference in New Orleans, investigators from the IVIRMA Global Research Alliance contributed further to the field, presenting 37 separate studies addressing clinically important questions that will continue to improve outcomes and help patients successfully grow their families.
  • Researchers from Reproductive Medicine Associates (RMA), the U.S. arm of IVIRMA Global, presented new research that could change fertility specialists' understanding of the factors impacting successful implantation, pregnancy and live birth.
  • A prior IVIRMA study had shown that there's a 95% chance of achieving a pregnancy in patients undergoing up to three consecutive single euploid embryo transfers.

Inception Fertility Proudly Sponsors the 2023 American Society for Reproductive Medicine's Congress & Expo

Retrieved on: 
Wednesday, October 18, 2023

HOUSTON, Oct. 18, 2023 /PRNewswire/ --  Continuing on its commitment to advance the field of reproductive medicine, Inception Fertility™ (Inception), the largest provider of comprehensive fertility products and services in North America, proudly announces its participation at 2023 ASRM Scientific Congress, taking place October 14-18, 2023, in New Orleans, Louisiana.

Key Points: 
  • HOUSTON, Oct. 18, 2023 /PRNewswire/ --  Continuing on its commitment to advance the field of reproductive medicine, Inception Fertility™ (Inception), the largest provider of comprehensive fertility products and services in North America, proudly announces its participation at 2023 ASRM Scientific Congress, taking place October 14-18, 2023, in New Orleans, Louisiana.
  • ASRM is a professional organization dedicated to advancing the science and practice of reproductive medicine.
  • Its annual Scientific Congress is a gathering of multi-disciplinary professionals who share the latest scientific breakthroughs and discoveries in reproductive endocrinology and infertility.
  • "Inception is honored to serve as a major sponsor of the ASRM Scientific Congress & Expo and embrace the organization's 2023 motto of Past, Present and Pipeline, which fall in line with our own commitment to advancing the field of reproductive medicine," says Nicole R. Braley, Chief Marketing Officer at Inception Fertility.

ARC® Fertility Leadership to Support ASRM Congress, October 14-18

Retrieved on: 
Saturday, October 14, 2023

ARC Fertility , a pioneer in innovative fertility and family-forming treatment options, will proudly be supporting the American Society for Reproductive Medicine (ASRM) 2023 Scientific Congress and Expo in New Orleans.

Key Points: 
  • ARC Fertility , a pioneer in innovative fertility and family-forming treatment options, will proudly be supporting the American Society for Reproductive Medicine (ASRM) 2023 Scientific Congress and Expo in New Orleans.
  • A longtime supporter of ASRM, ARC Fertility founder and CEO Dr. G. David Adamson previously served as president for the society.
  • He’ll be joined by ARC leadership for this year’s program.
  • “ASRM members are advancing medical science and delivering vital new marketplace solutions every day, and the annual ASRM Congress is critical to our field’s ongoing progress.

US Fertility's research team demonstrates commitment to improving outcomes for fertility patients at this year's ASRM Scientific Congress

Retrieved on: 
Monday, October 16, 2023

NEW ORLEANS, Oct. 16, 2023 /PRNewswire-PRWeb/ -- US Fertility's research team will present over 60 abstracts during the 2023 American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo as part of its commitment to advancing knowledge and improving assisted reproductive technology (ART) treatment outcomes.

Key Points: 
  • US Fertility's physician-scientists will present over 60 studies at this year's American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo.
  • NEW ORLEANS, Oct. 16, 2023 /PRNewswire-PRWeb/ -- US Fertility's research team will present over 60 abstracts during the 2023 American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo as part of its commitment to advancing knowledge and improving assisted reproductive technology (ART) treatment outcomes.
  • "As the largest partnership of physician-owned fertility practices in the United States, US Fertility is leading the way in reproductive medicine research."
  • "As the largest partnership of physician-owned fertility practices in the United States, US Fertility is leading the way in reproductive medicine research," shares Kate Devine, M.D.

ASRM ANNOUNCES HISTORIC $5 MILLION ENDOWMENT FROM FERRING PHARMACEUTICALS

Retrieved on: 
Monday, October 16, 2023

WASHINGTON and PARSIPPANY, N.J., Oct. 16, 2023 /PRNewswire/ -- The American Society for Reproductive Medicine (ASRM) and Ferring Pharmaceuticals today announced a historic $5 million endowment from Ferring to ASRM.  This endowment, the largest in ASRM's nearly 80-year history, will establish the "Ferring Endowment for the Education of Healthcare Professionals in Training," ensuring ASRM's continued legacy as the leading educator for professionals in the field.

Key Points: 
  • WASHINGTON and PARSIPPANY, N.J., Oct. 16, 2023 /PRNewswire/ -- The American Society for Reproductive Medicine (ASRM) and Ferring Pharmaceuticals today announced a historic $5 million endowment from Ferring to ASRM.
  • This endowment, the largest in ASRM's nearly 80-year history, will establish the "Ferring Endowment for the Education of Healthcare Professionals in Training," ensuring ASRM's continued legacy as the leading educator for professionals in the field.
  • We're honored to partner with ASRM to augment their learning opportunities at this important stage of their careers," said Jade Levi Shields, Vice President, Corporate Affairs, Ferring Pharmaceuticals.
  • "ASRM is immensely grateful to Ferring for this generous endowment that will address the longstanding need for more early career training in reproductive medicine.

Inception Fertility™ Announces 36 Abstracts Accepted, to be Presented at the 2023 ASRM Scientific Congress

Retrieved on: 
Monday, October 16, 2023

HOUSTON, Oct. 16, 2023 /PRNewswire/ -- Inception Fertility™ (Inception), the largest provider of comprehensive fertility products and services in North America, announces today 36 of abstracts from its clinical network, The Prelude Network® (Prelude), have been accepted by the American Society for Reproductive Medicine (ASRM) to be presented at the 2023 ASRM Scientific Congress, taking place October 14-18, 2023, in New Orleans, Louisiana.

Key Points: 
  • ASRM is a professional organization dedicated to advancing the science and practice of reproductive medicine.
  • Its annual Scientific Congress is a gathering of multi-disciplinary professionals who share the latest scientific breakthroughs and discoveries in reproductive endocrinology and infertility.
  • "We look forward to another year at the ASRM Scientific Congress and working in collaborative spirit with our colleagues to continue learning and growing this field of medicine."
  • To see a complete list of those Prelude abstracts that will be presented at the 2023 ASRM Scientific Congress, please visit Inception Fertility at ASRM 2023 Conference .

Life Whisperer Genetics AI launches in the USA: Revolutionizing Embryo Euploidy Assessment with Non-Invasive, Instant, and Affordable Technology

Retrieved on: 
Friday, October 13, 2023

Life Whisperer Genetics: Revolutionizing Embryo Euploidy Assessment with Non-Invasive, Instant, & Affordable Technology

Key Points: 
  • Life Whisperer Genetics: Revolutionizing Embryo Euploidy Assessment with Non-Invasive, Instant, & Affordable Technology
    Euploid embryos are selected for use in IVF as they are reported to have improved pregnancy and live birth outcomes.
  • Current approaches to assessing embryo euploidy include PGT-A, which is costly and requires an invasive biopsy of the embryo.
  • Life Whisperer Genetics allows IVF clinics to non-invasively rank, prioritize, and select good quality embryos based on euploidy with confidence, for confirmatory (PGT-A) testing or for transfer.
  • Life Whisperer is also exhibiting at the ASRM event to showcase Life Whisperer Genetics and its benefits to the local IVF fertility industry.

NEW EGG DONATION BANK LAUNCHES, PRIORITIZING DONOR TRANSPARENCY

Retrieved on: 
Thursday, October 12, 2023

BOSTON, Oct. 12, 2023 /PRNewswire/ -- Today, a first-of-its-kind fresh and frozen egg donation company Everie launched with a Mutual Match™ system that empowers both donors and recipient parents to prioritize transparency during the egg donation process, fostering the best outcomes for donors, parents, and donor-conceived individuals.

Key Points: 
  • This is the future of egg donor services," said Aisha Lewis, President of Everie and bioethicist with over 20 years of experience in assisted reproductive technology.
  • Everie allows donors and recipient parents to choose from four types of egg donation to suit different preferences and comfort levels: disclosed, semi-disclosed, ID release, and de-identified.
  • "Everie is challenging the egg donation model as the only company using a mutually empowering and transparent approach called Mutual Match™.
  • The traditional egg bank system has previously lacked overt consent from donors on who the recipient parents are for their genetic lineage," said Steuart Botchford, CEO of Northstar Fertility.